Related Experiment Video
Updated: May 28, 2025

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
Published on: September 14, 2014
Cysteines shape antibody battles for HIV-1 Env
1Center for Infectious Disease Research, Research Center for Industries of the Future, School of Medicine, School of Life Sciences, Westlake University, Hangzhou, 310024, Zhejiang, China.
Non-canonical cysteine residues in the HIV-1 V1 region are linked to broader neutralization. This finding offers insights into developing more effective HIV vaccines.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- The HIV-1 Envelope glycoprotein is a key target for neutralizing antibodies.
- Understanding the structural basis of neutralization breadth is crucial for vaccine development.
Purpose of the Study:
- To investigate the association between non-canonical cysteine residues in the HIV-1 V1 region and the development of neutralization breadth.
- To explore the role of these residues in HIV-1 evolution and immune evasion.
Main Methods:
- Population-based analyses of HIV-1 sequences.
- Bioinformatic analysis of the V1 region of the Envelope glycoprotein.
- Correlation studies between cysteine residue presence and neutralization breadth data.
Main Results:
- The presence of specific non-canonical cysteine residues in the HIV-1 V1 region was significantly associated with increased neutralization breadth.
- These residues may influence the conformational dynamics of the Envelope glycoprotein, impacting antibody binding.
Conclusions:
- Non-canonical cysteines in the HIV-1 V1 region represent an important factor contributing to neutralization breadth.
- Targeting these structural features could inform the design of novel HIV-1 vaccine strategies.
More Related Videos
07:29Determination of Molecular Structures of HIV Envelope Glycoproteins using Cryo-Electron Tomography and Automated Sub-tomogram Averaging
Published on: December 1, 2011
08:09Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017